Načítá se...
A state of the art review on the novel mediator asprosin in the metabolic syndrome
Metabolic syndrome is a complex and heterogeneous pathology characterized by a cluster of biochemical, clinical, and metabolic factors that came together in raising the risk of cardiovascular diseases, type 2 diabetes mellitus, and all-cause mortality. Some of these features are well defined in this...
Uloženo v:
| Vydáno v: | Porto Biomed J |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7732265/ https://ncbi.nlm.nih.gov/pubmed/33324783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/j.pbj.0000000000000108 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|